Skip to main content
SpringerLink
Log in

Bortezomib in combination with thalidomide and dexamethasone—a successful treatment regimen in refractory extramedullary multiple myeloma

  • Letter to the editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Blade J, Lust JA, Kyle RA (1994) Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol 12:2398–2404

    PubMed  CAS  Google Scholar 

  2. Pantelidou D, Tsatalas C, Margaritis D, Anastasiadis AG, Kaloutsi V, Argyropoulou P, Prassopoulos P, Bourikas G (2006) Successful treatment of lymph node extramedullary plasmacytoma with bortezomib. Ann Hematol 85:188–190

    Article  PubMed  CAS  Google Scholar 

  3. Rosinol L, Cibeira MT, Blade J, Esteve J, Aymerich M, Rozman M, Segarra M, Cid MC, Filella X, Montserrat E (2004) Extramedullary multiple myeloma escapes the effect of thalidomide. Haematologica 89:832–836

    PubMed  CAS  Google Scholar 

  4. Laura R, Cibeira MT, Uriburu C, Yantorno S, Salamero O, Bladé J, Montserrat E (2006) Bortezomib: an effective agent in extramedullary disease in multiple myeloma. Eur J Haematol 76:405–408

    Article  PubMed  Google Scholar 

  5. Harousseau JL, Attal M, Leleu X, Troncy J, Pegourie B, Stoppa AM, Hulin C, Benboubker L, Fuzibet JG, Renaud M, Moreau P, Avet-Loiseau H (2006) Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study. Haematologica 91:1498–1505

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Karol Marcinkowski University of Medical Sciences, ul. Szamarzewskiego 84, 60-569, Poznań, Poland

    Dominik Dytfeld, Magdalena Matuszak, Krzysztof Lewandowski & Mieczysław Komarnicki

Authors
  1. Dominik Dytfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Magdalena Matuszak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Krzysztof Lewandowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mieczysław Komarnicki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dominik Dytfeld.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dytfeld, D., Matuszak, M., Lewandowski, K. et al. Bortezomib in combination with thalidomide and dexamethasone—a successful treatment regimen in refractory extramedullary multiple myeloma. Ann Hematol 87, 253–254 (2008). https://doi.org/10.1007/s00277-007-0401-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-007-0401-8

Keywords

Search

Navigation